Mallinckrodt (MNK) ROE - Return on Equity

Current and historical Return on Equity (ROE) values for Mallinckrodt (MNK) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.426B $0.830B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.